Latest News
Featured News
Scancell updated Phase 2 data shows continued improvement in progression free survival with iSCIB1+
Welcome to WordPress. This is your first post. Edit or delete it, then start writing!
Select the category
Issue of share options
Scancell to present translational data from the Phase 2 ongoing SCOPE trial of SCIB1 at the 2025 AACR IO conference
Interim Results for the six months ended 31 October 2024
Notice of Interim Results
Scancell’s Modi-1 Moditope Vaccine Achieves Early Clinical Validation in Head and Neck Cancer
Scancell announces Genmab exercises option to a second commercial license agreement
No results found.
Regulatory News Archive
JOIN OUR MAILING LIST
Sign up for news updates to stay up to date with Scancell.